CPI-637 5 mg | 99.91%
TargetMol
CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor.
More Information Supplier PageCPI-637
Search Results
CPI-637 25 mg | 99.91%
TargetMol
CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor.
More Information Supplier PageCPI-637
HA15 10 mg | 98.00%
TargetMol
HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
More Information Supplier PageHA15
HA15 2 mg | 98.00%
TargetMol
HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
More Information Supplier PageHA15
Vesatolimod 25 mg | 99.92%
TargetMol
GS-9620 is an effective and specific orally active agonist of Toll-like receptor 7.
More Information Supplier PageVesatolimod
Vesatolimod 10 mg | 99.92%
TargetMol
GS-9620 is an effective and specific orally active agonist of Toll-like receptor 7.
More Information Supplier PageVesatolimod
Eltrombopag Olamine 200 mg | 99.87%
TargetMol
Eltrombopag Olamine is the orally active ethanolamine salt of eltrombopag, a small-molecule, nonpeptide thrombopoietin receptor agonist with megakaryopoiesis-stimulating activity. Eltrombopag binds to and stimulates the transmembrane domain of the platelet thrombopoietin receptor (TPO-R or CD110), a member of the hematopoietin receptor superfamily. Activation of TPO-R leads to the proliferation and differentiation of cells in the […]
More Information Supplier PageEltrombopag Olamine
Eltrombopag Olamine 25 mg | 99.87%
TargetMol
Eltrombopag Olamine is the orally active ethanolamine salt of eltrombopag, a small-molecule, nonpeptide thrombopoietin receptor agonist with megakaryopoiesis-stimulating activity. Eltrombopag binds to and stimulates the transmembrane domain of the platelet thrombopoietin receptor (TPO-R or CD110), a member of the hematopoietin receptor superfamily. Activation of TPO-R leads to the proliferation and differentiation of cells in the […]
More Information Supplier PageEltrombopag Olamine
Eltrombopag Olamine 5 mg | 99.87%
TargetMol
Eltrombopag Olamine is the orally active ethanolamine salt of eltrombopag, a small-molecule, nonpeptide thrombopoietin receptor agonist with megakaryopoiesis-stimulating activity. Eltrombopag binds to and stimulates the transmembrane domain of the platelet thrombopoietin receptor (TPO-R or CD110), a member of the hematopoietin receptor superfamily. Activation of TPO-R leads to the proliferation and differentiation of cells in the […]
More Information Supplier PageEltrombopag Olamine
CPI-637 100 mg | 99.91%
TargetMol
CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor.
More Information Supplier PageCPI-637